Connection

Suniti Misra to Hyaluronic Acid

This is a "connection" page, showing publications Suniti Misra has written about Hyaluronic Acid.
Connection Strength

3.641
  1. Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells. Bioorg Med Chem. 2013 May 01; 21(9):2551-9.
    View in: PubMed
    Score: 0.378
  2. Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 2011 May; 278(9):1429-43.
    View in: PubMed
    Score: 0.331
  3. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. J Biol Chem. 2010 Jun 25; 285(26):19821-32.
    View in: PubMed
    Score: 0.308
  4. Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE. J Biol Chem. 2009 May 01; 284(18):12432-46.
    View in: PubMed
    Score: 0.287
  5. Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol. 2008 Aug; 9(4):249-52.
    View in: PubMed
    Score: 0.276
  6. Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J Biol Chem. 2008 May 23; 283(21):14335-44.
    View in: PubMed
    Score: 0.268
  7. Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer. Connect Tissue Res. 2008; 49(3):219-24.
    View in: PubMed
    Score: 0.265
  8. Tissue-specific shRNA delivery: a novel approach for gene therapy in cancer. Connect Tissue Res. 2008; 49(3):265-9.
    View in: PubMed
    Score: 0.265
  9. Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. J Biol Chem. 2006 Nov 17; 281(46):34936-41.
    View in: PubMed
    Score: 0.242
  10. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. J Biol Chem. 2005 May 27; 280(21):20310-5.
    View in: PubMed
    Score: 0.218
  11. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem. 2003 Jul 11; 278(28):25285-8.
    View in: PubMed
    Score: 0.192
  12. Transforming growth factor ?1 (TGF?1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts. J Biol Chem. 2017 06 23; 292(25):10465-10489.
    View in: PubMed
    Score: 0.126
  13. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer. Matrix Biol. 2017 05; 59:3-22.
    View in: PubMed
    Score: 0.122
  14. Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis. J Biol Chem. 2014 Mar 21; 289(12):8545-61.
    View in: PubMed
    Score: 0.101
  15. Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest. 2006 Nov; 116(11):3026-34.
    View in: PubMed
    Score: 0.061
  16. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem. 2005 Mar 11; 280(10):8875-83.
    View in: PubMed
    Score: 0.054
  17. Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions. Cells Tissues Organs. 2005; 179(1-2):66-72.
    View in: PubMed
    Score: 0.054
  18. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res. 2004 Feb 15; 64(4):1229-32.
    View in: PubMed
    Score: 0.051
  19. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem. 2002 Oct 11; 277(41):38013-20.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.